Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Puratrophin 1 Inhibitors

Puratrophin 1 inhibitors are a class of chemical compounds that target the Puratrophin 1 protein, a molecular component involved in cellular signaling and regulatory pathways. Puratrophin 1, a member of a broader family of proteins with structural and functional significance, plays a role in various cellular processes. The inhibition of this protein by specific small molecules or macromolecular inhibitors leads to changes in cellular signaling cascades, potentially affecting the normal and aberrant regulation of physiological pathways. Puratrophin 1 inhibitors are often characterized by their ability to selectively bind to and modulate the activity of the Puratrophin 1 protein, either through direct binding to its active site or by inducing conformational changes that affect its function. Structurally, these inhibitors may possess diverse chemical backbones but share common features that confer specificity and high affinity for the Puratrophin 1 protein.

The structural diversity of Puratrophin 1 inhibitors allows them to interact with different domains or pockets within the protein, making them versatile in their mechanism of action. These inhibitors often exhibit various binding modes, including reversible or irreversible interactions, competitive or allosteric binding, and they can demonstrate varying levels of potency based on their chemical structures. In designing Puratrophin 1 inhibitors, chemical modifications can be made to enhance selectivity, stability, and binding efficiency. The physiochemical properties of these compounds, such as lipophilicity, polarity, and molecular size, influence their bioavailability and interactions with cellular targets. Furthermore, the specificity of Puratrophin 1 inhibitors can be fine-tuned through structure-activity relationship (SAR) studies, enabling the design of compounds with optimized inhibitory activity. These inhibitors are critical tools for studying the functional role of Puratrophin 1 in cellular signaling and for elucidating the protein's contributions to various biochemical pathways.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Can impact Wnt signaling, which might intersect with pathways regulated by Puratrophin 1.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

GSK-3 inhibitor known to modulate Wnt/β-catenin signaling, potentially affecting Puratrophin 1 related pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibitor of MEK, which can affect MAPK/ERK pathway, likely intersecting with Puratrophin 1 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can influence autophagy and protein degradation pathways, potentially altering Puratrophin 1 function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can affect Akt signaling, possibly intersecting with Puratrophin 1 regulatory mechanisms.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Specific inhibitor of V-ATPase that can disrupt lysosomal acidification and autophagy, affecting Puratrophin 1 function.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Hedgehog signaling pathway inhibitor that can modify cellular processes potentially regulated by Puratrophin 1.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibitor of JNK, which may influence signaling pathways involving Puratrophin 1.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$96.00
$355.00
69
(1)

Inhibitor of BMP signaling that could intersect with Puratrophin 1-related pathways.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Signaling molecule that regulates gene expression and may affect pathways involving Puratrophin 1.